Roots Analysis
JANUARY 23, 2024
Owing to the challenges involved in the synthesis process and demands of modern drug development, majority of drug developers in this domain prefer to outsource their development and manufacturing operations to peptide therapeutics contract API manufacturers as a strategic solution to streamline their research and peptide synthesis efforts.
The Pharma Data
AUGUST 20, 2020
The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. DEVELOP A UNIFIED SCIENTIFIC VOICE. Virtual Event.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 31, 2020
where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies.
Roots Analysis
AUGUST 15, 2024
Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine. Author Bio: Gaurav Raj Bangarh Gaurav Raj Bangarh is a business research analyst and competitive intelligence professional.
The Pharma Data
DECEMBER 28, 2020
Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. in its healthcare practice and conducted postdoctoral research in diabetes-related drug development at Boston University’s School of Medicine. ” ABOUT NOVOTECH HEALTH HOLDINGS.
Roots Analysis
AUGUST 12, 2024
Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine. These tests can identify biomarkers, genetic markers, and other molecular indicators that are associated with the development and progression of neurological diseases.
Pharmaceutical Technology
JANUARY 27, 2023
In 2019, Cablivi became the first FDA-approved , nanobody-based medicine for acquired thrombotic thrombocytopenic purpura (aTTP), an ultra-orphan condition that causes blood clots in small blood vessels around the body. The disorder has a reported annual incidence between 1.5 cases per million in Europe.
Expert insights. Personalized for you.
40 
Let's personalize your content